Laboratorio Reig Jofre SA
MAD:RJF

Watchlist Manager
Laboratorio Reig Jofre SA Logo
Laboratorio Reig Jofre SA
MAD:RJF
Watchlist
Price: 3.15 EUR 2.61% Market Closed
Market Cap: 254.8m EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

RJF Price Targets Summary
Laboratorio Reig Jofre SA

There are no price targets for RJF.
RJF Lowest Forecast
Wall Street Target
Not Available
RJF Average Forecast
Wall Street Target
Not Available
RJF Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Laboratorio Reig Jofre SA Competitors:
Price Targets
C
300765
CSPC Innovation Pharmaceutical Co Ltd
1% Downside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
23% Upside
E
ENZY
Enzymatica AB (publ)
11% Downside
PFE
Pfizer Inc
26% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
1% Downside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
23% Upside
E
ENZY
Enzymatica AB (publ)
11% Downside
PFE
Pfizer Inc
26% Upside
1177
Sino Biopharmaceutical Ltd
15% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
16% Upside
300725
PharmaBlock Sciences Nanjing Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Laboratorio Reig Jofre SA

For the last 8 years the compound annual growth rate for Laboratorio Reig Jofre SA's revenue is 10%. The projected CAGR for the next 2 years is 7%.

10%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Laboratorio Reig Jofre SA

For the last 8 years the compound annual growth rate for Laboratorio Reig Jofre SA's operating income is 5%. The projected CAGR for the next 2 years is 18%.

5%
Past Growth
18%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Laboratorio Reig Jofre SA

For the last 8 years the compound annual growth rate for Laboratorio Reig Jofre SA's net income is 4%. The projected CAGR for the next 2 years is 25%.

4%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-21%
Average Miss
What are analyst estimates?

See Also

Summary
RJF intrinsic value, competitors valuation, and company profile.
DCF Valuation
RJF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RJF stock valuation using valuation multiples.
Wall Street Estimates
RJF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RJF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RJF's stock price target?
Not Available

RJF doesn't have any price targets made by Wall Street professionals.

What is Laboratorio Reig Jofre SA's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Laboratorio Reig Jofre SA's revenue is 10%. The projected CAGR for the next 2 years is 7%.

What is Laboratorio Reig Jofre SA's Operating Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Laboratorio Reig Jofre SA's operating income is 5%. The projected CAGR for the next 2 years is 18%.

What is Laboratorio Reig Jofre SA's Net Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Laboratorio Reig Jofre SA's net income is 4%. The projected CAGR for the next 2 years is 25%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.